Physician profile

Ankur Bharat Patel

Pain Medicine (Anesthesiology) · Gainesville, GA

NPI 1780971994

$21,388.41

in general payments reported to CMS, 2019-2025

42 companies · $1,614 in 2025

The $1,614 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).

See the full distribution for Pain Medicine (Anesthesiology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,480.60
Travel and Lodging$3,290.59
Education$361.61

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $4,776.37 2021-2025 Intellis Adaptivestim, Inceptiv, Accurian
Abbott Laboratories $4,131.97 2019-2025 Proclaim, Eterna, Mitraclip
Saluda Medical Americas, INC. $3,491.97 2022-2024 Evoke Scs, Evoke
Boston Scientific Corporation $3,077.32 2019-2025 Intracept, General - Pain Management, Wavewriter Alpha Prime 16
Nevro Corp. $1,328.81 2019-2024 Senza
Stimwave Technologies Incorporated $913.63 2021-2022
Medtronic USA, INC. $563.99 2019-2020
Biotronik Nro, INC. $555.92 2023-2025 Prospera, Biotronik
Curonix LLC $337.18 2023-2024 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Painteq LLC $296.51 2022-2024 Painteq
Spr Therapeutics, INC $280.75 2022-2025 Sprint Pns System
Mml US, INC. $223.20 2023-2025 Reactiv8
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $151.63 2019-2020
Grt US Holding, INC. $120.51 2022
Biodelivery Sciences International, INC. $114.64 2019
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Scilex Pharmaceuticals INC. $112.90 2020
Foundation Fusion Solutions, LLC $108.67 2021-2025
Collegium Pharmaceutical, INC. $107.74 2023-2024 Belbuca, Xtampza
Nalu Medical, INC. $104.03 2021-2024 Nalu Neurostimulation System
Relievant Medsystems, INC. $69.90 2023 Intracept
Forte Bio-Pharma LLC $54.19 2021-2023 Prolate, Nalocet
Tenex Health INC. $46.55 2020
Averitas Pharma INC. $44.22 2023 Qutenza
Pfizer INC. $38.60 2019-2020
Merz Pharmaceuticals, LLC $35.90 2022
Bioventus LLC $28.18 2022
Spinal Simplicity, LLC $26.96 2025 Ha Minuteman G3-R
Abbvie INC. $24.39 2024
Ultragenyx Pharmaceutical INC. $22.88 2022
Vertos Medical, INC. $22.06 2023 Mild Device Kit
Trevena, INC. $19.13 2023 Olinvyk
Valinor Pharma, LLC $18.90 2025 Movantik
Corium, LLC $17.26 2023 Azstarys
Baudax Bio INC. $17.22 2020
Horizon Therapeutics Plc $15.71 2020
Arbor Pharmaceuticals, INC. $15.54 2020
Fidia Pharma USA INC. $15.42 2022
Si-Bone, INC. $15.26 2025
Arteriocyte Medical Systems, INC. $14.76 2019
Protega Pharmaceutials INC $12.69 2022
Pacira Therapeutics, INC. $11.37 2021
Merit Medical Systems INC $3.58 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ankur Bharat Patel

$21,388.41

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $1,614 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).

https://glasscript.com/doctor/1182759/ankur-bharat-patel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.